Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
February 2007  
Untitled Document
Sections

Market
Radiology Buzz
Strategy
Knowledge
Healthcare Life
WeekEnd

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
Network Magazine India
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express
Home - Market - Article

Expansion

Dr Lal PathLabs to have 50 lab—networks across India by 2009

Dr Lal PathLabs, India's largest pathology chain, will have a network of 50 laboratories across the country by March 2009. The expansion strategy will be powered by a mix of acquisitions and setting up own laboratories. The acquisitions will be funded through internal accruals, venture fund Sequoia Capital and debentures.

Said Dr Arvind Lal, Chairman & Managing Director, Dr Lal PathLabs, "Given our credentials of being the oldest and the most sophisticated lab in the country and having successfully operated 20 labs all over India, we sensed a great need of setting up of quality testing labs across India especially since 70 per cent of treatment decisions are based on laboratory tests."

The lack of Governmental regulation and accreditation have resulted in proliferation of approximately 40,000 unorganised labs all over the country, where quality is mostly compromised, thus resulting in poor patient care and management.

Dr Lal PathLabs is accredited by the College of American Pathologists (CAP) and the National Accreditation Board for Testing and Calibration Laboratories (NABL). The company is, therefore, poised to take its quality services into different parts of India.

Global trends support the consolidation theory. The US market size is $40 billion compared to $750 million in India. A comparison between the US and Indian data shows that the top three players in the US market control about 50 per cent while in India, the top five players just about manage an abysmal 8-10 per cent among themselves.

Said Dr O P Manchanda, COO, Dr Lal PathLabs, "Dr Lal PathLabs has set for itself the goal of leading the process of consolidation and garner a market share of 10 per cent in the next two-three years."

The company foresees an organised growth for the Indian diagnostic industry with multiple acquisitions and tie-ups among Indian and global players. In the current financial year, the company would be doubling its infrastructure to 25 labs; of which 24 are greenfield ventures.

EH News Bureau

 


Untitled Document

Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.